Atlas Trials

Non-myeloid Malignancies

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Non-myeloid Malignancies

RecordFirmDate
A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoiesis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA) (NCT01145638)Pharmacosmos A/S2010-10-01
Darbepoetin Alfa With or Without Intravenous (IV) Iron (NCT00401544)Amgen2006-12-01
Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies (NCT00239239)Amgen2005-08-01
A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy (NCT00118638)Amgen2004-03-01
Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy (NCT00110955)Amgen2004-02-01
Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy (NCT00111137)Amgen2003-02-01
Darbepoetin Alfa and Anemia of Cancer (NCT00989092)Amgen2002-05-01
Chemotherapy Related Anemia (NCT00035607)Amgen2001-12-01
Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Darbepoetin Alfa (NCT00540696)Amgen2001-09-01
Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle Chemotherapy (NCT00111462)Amgen

Track Non-myeloid Malignancies automatically

Every clearance here is in the API, with alerts when new ones post.